✦ LIBER ✦

Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study

✍ Scribed by Nelson Barrientos; Pedro Chana

Publisher: Springer
Year: 2003
Tongue: English
Weight: 157 KB
Volume: 4
Category: Article
ISSN: 1129-2369
DOI: 10.1007/s10194-003-0049-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin type-A in the prophylact

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

✍ Giorgio Sandrini; Armando Perrotta; Cristina Tassorelli; Paola Torelli; Filippo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Botulinum toxin type-A therapy in cluste

Botulinum toxin type-A therapy in cluster headache: an open study

✍ Petra Sostak; Phillip Krause; Stefanie Förderreuther; Veronika Reinisch; Andreas 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 71 KB

A one-year prospective costing study of

A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache

✍ Fabio Palazzo; Francesco G. Mennini; Laura Fioravanti; Laura Piasini; Gabriella 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

An open label, randomised, pilot study o

An open label, randomised, pilot study of botulinum toxin type-A in the treatment of chronic tension-type headache

✍ Mauro Porta; Giorgio Maggioni 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 120 KB

Efficacy of botulinum toxin type A in ne

Efficacy of botulinum toxin type A in new daily persistent headache

✍ Roderick C. Spears 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 78 KB

BotB (botulinum Toxin type B): Evaluatio

BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-Resistant cervical dystonia patients (preliminary study)

✍ Dr. Daniel D. Truong; Paul A. Cullis; Christopher F. O'Brien; Martin Koller; Tim 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses